Literature DB >> 36187517

Secondary and Quaternary Delays in the Diagnosis of Breast Cancer: Are the Physicians Responsible too?

Soumen Das1, Radha Raman Mondal2, Abhimanyu Basu3.   

Abstract

Causes of delay in presentation of breast cancer has been categorised into 'Primary Delay' (delay by the patient or her family); 'Secondary Delay' (delay by the doctors in the first contact - family physician or quacks/alternative medicine practitioners); 'Tertiary Delay' (delay in the system in a specialist breast care unit e.g. waiting list, delayed reporting, doctors on leave, strikes); and 'Quaternary Delay' (e.g. patient hopping from one competent breast cancer specialist to another or mid-course attrition to alternative treatments). In India, many patients have blind belief and high attrition towards the quacks and alternative medicine practitioners. Our study was to assess whether these 'Secondary and Quaternary Delays', particularly the attrition towards the alternative non-modern medical practitioners, have any effect on the delayed presentation and advancement of the overall anatomical staging among the breast cancer patients. We performed a retrospective observational study, based on 'Triple Assessment' and pre-structured Questionnaire. All pathologically confirmed female breast cancer patients admitted from 02/2017 to 08/2018 in the department of General Surgery in our Institute were included. Male breast cancer, histopathologically unconfirmed/inconclusive breast lumps, patients with previous breast surgery/radiotherapy/chemotherapy were excluded. Data from 267 patients was analysed. The mean age at presentation of breast cancer was 47.54 years. The average delay between the onset of the first symptom and the histological diagnosis was 13.76 ± SD 13.08 months. About half (50.2%) of our patients visited the non-modern medical practitioners at least once during their disease. The mean delay in diagnosis was significantly higher (p < 0.0001) among them. The average 'Secondary Delay' was significantly higher among those who visited the non-modern medical practitioners (9.7 ± SD 9.38 months). The average delay between the visit to the first doctor and the histological diagnosis was also significantly higher among them (18.35 ± 14 months). Patients with attrition to non-modern medical practitioners also were diagnosed in higher cT stages: cT4a (66.67%, 2 of 3) and cT4b (60%, 33 of 55). Most (56.9%) of stage IIIB patients visited the non-modern medical practitioners before their diagnosis. Patients who visited the non-modern medical practitioners had significantly more delay in the diagnosis of breast cancer. The 'Secondary and Quaternary Delays' form the major portion in the overall delay and lead to advancement of the anatomical staging of the disease. Creating public awareness, proper training and 'continued medical education' for primary care physicians, and the AYUSH practitioners are required. Further population-based studies are advised.
© The Author(s), under exclusive licence to Indian Association of Surgical Oncology 2022.

Entities:  

Keywords:  AYUSH; Alternative medicine; Ayurveda; Breast Cancer; Delay in diagnosis; Homeopathy; Non-modern medicine; Secondary delay; Tertiary delay

Year:  2022        PMID: 36187517      PMCID: PMC9515288          DOI: 10.1007/s13193-022-01527-5

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  22 in total

1.  Delays in diagnosis and treatment of breast cancer: a multinational analysis.

Authors:  Jacek Jassem; Vahit Ozmen; Florin Bacanu; Monika Drobniene; Janis Eglitis; Kuntegowdanahalli C Lakshmaiah; Zsuzsanna Kahan; Jozef Mardiak; Tadeusz Pieńkowski; Tatiana Semiglazova; Ljiljana Stamatovic; Constanta Timcheva; Suzana Vasovic; Damir Vrbanec; Piotr Zaborek
Journal:  Eur J Public Health       Date:  2013-09-12       Impact factor: 3.367

2.  An investigation of delay in treatment of breast cancer.

Authors:  H S Shukla; S Kumar; K Avasthi; Y P Naithani
Journal:  Indian J Med Res       Date:  1981-05       Impact factor: 2.375

3.  Clinico-morphological profile and receptor status in breast cancer patients in a South Indian institution.

Authors:  Saptarshi Ghosh; Shreyasee Sarkar; Samara Simhareddy; Sivasankar Kotne; Pammidimukkala Bramh Ananda Rao; Satya Prakash Venkatachalam Turlapati
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  Oncologist perspectives on breast cancer screening in India- results from a qualitative study in Andhra Pradesh.

Authors:  Srikanthi Lakshmi Bodapati; Giridhara Rathnaiah Babu
Journal:  Asian Pac J Cancer Prev       Date:  2013

5.  Delay in breast cancer diagnosis: a Brazilian cohort study.

Authors:  G C Medeiros; L C S Thuler; A Bergmann
Journal:  Public Health       Date:  2019-01-12       Impact factor: 2.427

6.  Breast cancer in Iran: results of a multi-center study.

Authors:  Iraj Harirchi; Mojgan Karbakhsh; Amir Kashefi; Amir Javad Momtahen
Journal:  Asian Pac J Cancer Prev       Date:  2004 Jan-Mar

7.  Delay in presentation to the hospital and factors affecting it in breast cancer patients attending tertiary care center in Central India.

Authors:  N A Thakur; A Y Humne; L B Godale
Journal:  Indian J Cancer       Date:  2015 Jan-Mar       Impact factor: 1.224

8.  Delay in Diagnosis and Treatment of Breast Cancer among Women Attending a Reference Service in Brazil

Authors:  Tiara Cristina Romeiro Lopes; Angela Andréia França Gravena; Marcela de Oliveira Demitto; Deise Helena Pelloso Borghesan; Cátia Millene Dell`Agnolo; Sheila Cristina Rocha Brischiliari; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

9.  Stage-Specific Survival Rate of Breast Cancer Patients in Northern Thailand in Accordance with Two Different Staging Systems.

Authors:  Imjai Chitapanarux; Patumrat Sripan; Areewan Somwangprasert; Chaiyut Charoentum; Wimrak Onchan; Kirati Watcharachan; Panchaporn Wongmaneerung; Pailin Kongmebhol; Bongkot Jia-Mahasap; Lalita Huntrakul
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

10.  Breast Cancer Survival in Sri Lanka.

Authors:  Jayantha Balawardena; Thurairajah Skandarajah; Wasantha Rathnayake; Nuradh Joseph
Journal:  JCO Glob Oncol       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.